HRP20110346T1 - Farmaceutski pripravak koji sadrži gabapentin - Google Patents
Farmaceutski pripravak koji sadrži gabapentin Download PDFInfo
- Publication number
- HRP20110346T1 HRP20110346T1 HR20110346T HRP20110346T HRP20110346T1 HR P20110346 T1 HRP20110346 T1 HR P20110346T1 HR 20110346 T HR20110346 T HR 20110346T HR P20110346 T HRP20110346 T HR P20110346T HR P20110346 T1 HRP20110346 T1 HR P20110346T1
- Authority
- HR
- Croatia
- Prior art keywords
- gabapentin
- granulate
- capsule
- tablet
- weight
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title claims abstract 48
- 229960002870 gabapentin Drugs 0.000 title claims abstract 24
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000008187 granular material Substances 0.000 claims abstract 18
- 230000008018 melting Effects 0.000 claims abstract 6
- 238000002844 melting Methods 0.000 claims abstract 6
- 239000000203 mixture Substances 0.000 claims 12
- 239000002775 capsule Substances 0.000 claims 11
- 239000000654 additive Substances 0.000 claims 8
- 239000007903 gelatin capsule Substances 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000007884 disintegrant Substances 0.000 claims 2
- 239000000945 filler Substances 0.000 claims 2
- 239000000314 lubricant Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 230000003179 granulation Effects 0.000 claims 1
- 238000005469 granulation Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Gabapentin granulat, naznačen time što se dobiva granulacijom gabapentina pomoću taljenja PEG-a koji ima točku taljenja između 50 i 80°C. Patent sadrži još 17 patentnih zahtjeva.
Claims (18)
1. Gabapentin granulat, naznačen time što se dobiva granulacijom gabapentina pomoću taljenja PEG-a koji ima točku taljenja između 50 i .
2. Granulat prema zahtjevu 1, naznačen time što je gabapentin prisutan u količini većoj od 80% težinski.
3. Granulat prema zahtjevu 1, naznačen time što je gabapentin prisutan u količinama većim od 90% težinski.
4. Granulat prema zahtjevu 1, naznačen time što je gabapentin prisutan u količinama jednakim 98% težinski, a PEG je 2%.
5. Farmaceutska smjesa gabapentina, naznačena time što je u obliku tablete dobivene komprimiranjem granulata iz zahtjeva 1.
6. Farmaceutska smjesa gabapentina, naznačena time što je u obliku kapsule dobivene punjenjem želatinske kapsule granulatom iz zahtjeva 1.
7. Farmaceutska smjesa gabapentina, naznačena time što je u obliku tablete dobivene komprimiranjem granulata iz zahtjeva 1 i poznatih aditiva koji su korisni za pripremu tableta.
8. Farmaceutska smjesa gabapentina u obliku tablete prema zahtjevu 7, naznačena time što se aditivi izabiru između punila, sredstava za podmazivanje, sredstava za raspadanje i sredstava za klizenje.
9. Farmaceutska smjesa gabapentina u obliku tablete prema zahtjevu 7, naznačena time što aditivi predstavljaju između 0 i 30% težine tablete i poželjno između 0 i 20% težine tablete, a ostatak do 100% čini granulat iz zahtjeva 1.
10. Farmaceutska smjesa gabapentina, naznačena time što je u obliku kapsule dobivene punjenjem želatinske kapsule granulatom iz zahtjeva 1 i poznatim aditivima koji su korisni za pripremu farmaceutskih oblika kapsula.
11. Farmaceutska smjesa gabapentina u obliku kapsule prema zahtjevu 10, naznačena time što aditivi predstavljaju između 0 i 30% težine sadržaja kapsule i poželjno između 0 i 20% težine sadržaja kapsule, a ostatak do 100% čini granulat iz zahtjeva 1.
12. Gabapentin granulat, naznačen time što se dobiva granulacijom gabapentina pomoću taljenja PEG-a koji ima točku taljenja između i aditiva poznatih za pripremu čvrstih farmaceutskih oblika izabranih između tableta i kapsula.
13. Gabapentin granulat koji se dobiva granulacijom gabapentima prema zahtjevu 12, naznačen time što se aditivi izabiru između punila, sredstava za podmazivanje, sredstava za raspadanje i sredstava za klizenje.
14. Granulat prema zahtjevu 12, naznačen time što ima sljedeći sastav:
gabapentin 70-98% težinski
PEG 2-25% težinski
aditivi 0-20% težinski
ukupno 100%.
15. Farmaceutska smjesa gabapentina u obliku tablete, naznačena time što se tableta dobiva komprimiranjem granulata prema zahtjevu 12.
16. Farmaceutska smjesa gabapentina u obliku kapsule, naznačena time što se kapsula dobiva punjenjem želatinske kapsule granulatom prema zahtjevu 12.
17. Kemijska smjesa gabapentina u obliku tablete ili kapsule, naznačena time što sadrži granulat prema zahtjevu 1.
18. Kemijska smjesa gabapentina u obliku tablete ili kapsule, naznačena time što sadrži granulat prema zahtjevu 12.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002399A ITMI20032399A1 (it) | 2003-12-09 | 2003-12-09 | Composizione farmaceutica contenente gabapentina. |
| PCT/EP2004/053233 WO2005055993A2 (en) | 2003-12-09 | 2004-12-02 | Pharmaceutical preparation containing gabapentin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110346T1 true HRP20110346T1 (hr) | 2011-06-30 |
Family
ID=34674559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110346T HRP20110346T1 (hr) | 2003-12-09 | 2011-05-10 | Farmaceutski pripravak koji sadrži gabapentin |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20080194687A1 (hr) |
| EP (1) | EP1699438B1 (hr) |
| JP (1) | JP5432433B2 (hr) |
| CN (1) | CN100508966C (hr) |
| AT (1) | ATE506052T1 (hr) |
| AU (1) | AU2004296561B2 (hr) |
| BR (1) | BRPI0417420B1 (hr) |
| CA (1) | CA2546476C (hr) |
| DE (1) | DE602004032382D1 (hr) |
| DK (1) | DK1699438T3 (hr) |
| EA (1) | EA012068B1 (hr) |
| ES (1) | ES2363503T3 (hr) |
| HR (1) | HRP20110346T1 (hr) |
| IL (1) | IL175764A (hr) |
| IT (1) | ITMI20032399A1 (hr) |
| NZ (1) | NZ547764A (hr) |
| PL (1) | PL1699438T3 (hr) |
| PT (1) | PT1699438E (hr) |
| SI (1) | SI1699438T1 (hr) |
| WO (1) | WO2005055993A2 (hr) |
| ZA (1) | ZA200604717B (hr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009044426A1 (ja) * | 2007-10-02 | 2009-04-09 | Shimadzu Corporation | 分取精製装置 |
| USD657242S1 (en) | 2010-01-14 | 2012-04-10 | S.C. Johnson & Son, Inc. | Container with nozzle |
| WO2017204582A1 (en) * | 2016-05-27 | 2017-11-30 | Hanmi Pharm. Co., Ltd. | Pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof inhibiting growth of cancer cells and a stabilizer having low melting point |
| RU2731536C1 (ru) * | 2019-07-30 | 2020-09-04 | Общество С Ограниченной Ответственностью "Консорциум-Пик" | Фармацевтические композиции, содержащие фенозановую кислоту |
| RU2736479C1 (ru) * | 2019-07-30 | 2020-11-17 | Общество С Ограниченной Ответственностью "Консорциум-Пик" | Не содержащая наполнитель фармацевтическая композиция, содержащая фенозановую кислоту |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE621097A (hr) * | 1961-08-05 | |||
| US3147187A (en) * | 1962-09-10 | 1964-09-01 | Don Hall Lab | Sustained release pharmaceutical |
| JPS58214333A (ja) * | 1982-06-04 | 1983-12-13 | Dai Ichi Seiyaku Co Ltd | 粒状物 |
| US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
| US5169645A (en) * | 1989-10-31 | 1992-12-08 | Duquesne University Of The Holy Ghost | Directly compressible granules having improved flow properties |
| US5078990A (en) * | 1990-07-13 | 1992-01-07 | Helene Curtis, Inc. | Shampoos and conditioning shampoos having increased capacity for incorporation of conditioning agents and removal of hair soil |
| US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
| US5429825A (en) * | 1992-06-26 | 1995-07-04 | Mcneil-Ppc, Inc. | Rotomelt granulation |
| EP0818990A1 (en) * | 1995-04-03 | 1998-01-21 | Abbott Laboratories | Homogeneous mixtures of low temperature-melting drugs and additives for controlled release |
| DE69828635T2 (de) * | 1997-09-19 | 2005-06-16 | Shire Laboratories, Inc. | Feste lösungskügelchen |
| EP1077691B1 (en) | 1998-05-15 | 2008-09-10 | Warner-Lambert Company LLC | Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| IL125244A (en) | 1998-07-07 | 2002-12-01 | Yissum Res Dev Co | Pharmaceutical compositions containing low-melting waxes |
| FR2781793B1 (fr) * | 1998-08-03 | 2001-07-20 | Prographarm Lab | Procede de fabrication de granules de gabapentine enrobes |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US7374779B2 (en) | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| US20020015730A1 (en) * | 2000-03-09 | 2002-02-07 | Torsten Hoffmann | Pharmaceutical formulations and method for making |
| US7056951B2 (en) * | 2000-09-26 | 2006-06-06 | Mutual Pharmaceutical Co., Inc. | Stable solid dosage forms of amino acids and processes for producing same |
| ATE327737T1 (de) * | 2001-03-07 | 2006-06-15 | Dainippon Sumitomo Pharma Co | Verfahren zur herstellung von arzneistoffgranulatkörnern, die arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische zubereitungen |
| ITMI20011337A1 (it) | 2001-06-26 | 2002-12-26 | Farmatron Ltd | Composizioni farmaceutiche orali a rilascio modificato del principio attivo |
| TWI312285B (en) * | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
| AU2003221535A1 (en) | 2002-03-28 | 2003-10-13 | Synthon B.V. | Venlafaxine besylate |
| WO2004032905A1 (en) * | 2002-10-08 | 2004-04-22 | Ranbaxy Laboratories Limited | Gabapentin tablets and methods for their preparation |
-
2003
- 2003-12-09 IT IT002399A patent/ITMI20032399A1/it unknown
-
2004
- 2004-12-02 CA CA2546476A patent/CA2546476C/en active Active
- 2004-12-02 NZ NZ547764A patent/NZ547764A/en unknown
- 2004-12-02 PT PT04804655T patent/PT1699438E/pt unknown
- 2004-12-02 US US10/581,367 patent/US20080194687A1/en not_active Abandoned
- 2004-12-02 BR BRPI0417420-8A patent/BRPI0417420B1/pt active IP Right Grant
- 2004-12-02 ES ES04804655T patent/ES2363503T3/es active Active
- 2004-12-02 AU AU2004296561A patent/AU2004296561B2/en active Active
- 2004-12-02 PL PL04804655T patent/PL1699438T3/pl unknown
- 2004-12-02 DE DE602004032382T patent/DE602004032382D1/de active Active
- 2004-12-02 DK DK04804655.1T patent/DK1699438T3/da active
- 2004-12-02 AT AT04804655T patent/ATE506052T1/de active
- 2004-12-02 CN CNB2004800366347A patent/CN100508966C/zh active Active
- 2004-12-02 JP JP2006543535A patent/JP5432433B2/ja active Active
- 2004-12-02 EA EA200600939A patent/EA012068B1/ru unknown
- 2004-12-02 WO PCT/EP2004/053233 patent/WO2005055993A2/en active Application Filing
- 2004-12-02 SI SI200431665T patent/SI1699438T1/sl unknown
- 2004-12-02 EP EP04804655A patent/EP1699438B1/en active Active
-
2006
- 2006-05-18 IL IL175764A patent/IL175764A/en active IP Right Grant
- 2006-06-08 ZA ZA200604717A patent/ZA200604717B/xx unknown
-
2011
- 2011-04-06 US US13/081,036 patent/US8927017B2/en active Active
- 2011-05-10 HR HR20110346T patent/HRP20110346T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE506052T1 (de) | 2011-05-15 |
| WO2005055993A3 (en) | 2006-05-26 |
| ES2363503T3 (es) | 2011-08-05 |
| JP2007513920A (ja) | 2007-05-31 |
| BRPI0417420A (pt) | 2007-03-06 |
| PT1699438E (pt) | 2011-07-05 |
| AU2004296561A1 (en) | 2005-06-23 |
| CA2546476A1 (en) | 2005-06-23 |
| AU2004296561B2 (en) | 2009-02-26 |
| NZ547764A (en) | 2009-09-25 |
| IL175764A (en) | 2012-08-30 |
| CA2546476C (en) | 2012-01-31 |
| DE602004032382D1 (de) | 2011-06-01 |
| ZA200604717B (en) | 2007-03-28 |
| SI1699438T1 (sl) | 2011-09-30 |
| PL1699438T3 (pl) | 2011-10-31 |
| DK1699438T3 (da) | 2011-08-15 |
| WO2005055993A2 (en) | 2005-06-23 |
| US20110189272A1 (en) | 2011-08-04 |
| JP5432433B2 (ja) | 2014-03-05 |
| CN100508966C (zh) | 2009-07-08 |
| EA200600939A1 (ru) | 2006-12-29 |
| EP1699438A2 (en) | 2006-09-13 |
| IL175764A0 (en) | 2008-04-13 |
| EA012068B1 (ru) | 2009-08-28 |
| US8927017B2 (en) | 2015-01-06 |
| ITMI20032399A1 (it) | 2005-06-10 |
| BRPI0417420B1 (pt) | 2021-10-13 |
| US20080194687A1 (en) | 2008-08-14 |
| EP1699438B1 (en) | 2011-04-20 |
| CN1889934A (zh) | 2007-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110346T1 (hr) | Farmaceutski pripravak koji sadrži gabapentin | |
| AR041370A1 (es) | Formulaciones farmaceuticas solidas que comprenden telmisartano y su preparacion | |
| EA200801926A1 (ru) | Таблетки парацетамола с быстрым высвобождением | |
| MXPA05007346A (es) | Tableta de goma de mascar comprimida. | |
| WO2008014175A3 (en) | Granular pharmaceutical compositions | |
| CO5611118A2 (es) | Formulaciones de azitromicina granuladas por via seca | |
| RS54559B1 (en) | APIKSABAN FORMULATIONS | |
| HRP20070322T3 (hr) | Tablete venlafaksin hidroklorida | |
| NZ593132A (en) | Balsalazide formulations and manufacture and use thereof | |
| AR061093A1 (es) | Composiciones de calcio | |
| MXPA06000791A (es) | Formulaciones farmaceuticas. | |
| EA201591097A1 (ru) | Фармацевтическая композиция, содержащая кандесартана цилексетил и амлодипин | |
| EA201100288A1 (ru) | Таблетки телмисартана | |
| ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
| MX2013001653A (es) | Granulado farmaceutico que comprende mesilato de imatinib | |
| SE0200154D0 (sv) | New process | |
| PT1818048E (pt) | Formulações farmacêuticas de polímeros aminados alifáticos e processos para a sua produção | |
| MXPA02010828A (es) | Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. | |
| EA200301282A1 (ru) | Гранулярные препараты габоксадола | |
| PL354823A1 (en) | Prolonged effect containing indapamide and method of manufacture of prolonged effect tablets containing indapamide | |
| ATE508737T1 (de) | Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzung | |
| RU2006119505A (ru) | Стабилизированная композиция азитромицина | |
| JP2012046484A5 (hr) | ||
| ATE307579T1 (de) | Pektin und ascorbinsäure enthaltende zusammensetzungen | |
| JP4899304B2 (ja) | 塩酸アンブロキソール含有内服用固形製剤 |